FAST Announces Funding For First Innovative Seed Grant
FAST has awarded its first Innovative Seed Grant to Drs. Rachel Cunningham and Jennifer Adair to develop a safer, more accessible hematopoietic stem cell therapy approach for Angelman syndrome that avoids risky chemotherapy-based conditioning.